Santa Cruz Biotechnology offers a broad range of CD209b monoclonal antibodies for research focused on understanding CD209b protein function. CD209b monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD209b, also known as DC-SIGN, is a C-type lectin receptor primarily expressed on dendritic cells and macrophages. CD209b plays a crucial role in the immune response by mediating the recognition and uptake of pathogens, as well as facilitating T-cell activation. Understanding CD209b function is essential for elucidating mechanisms of immune regulation and pathogen-host interactions. CD209b monoclonal antibodies enable precise detection and characterization of CD209b expression patterns across different cell types. Researchers can utilize CD209b monoclonal antibodies to investigate cellular localization and protein-protein interactions. CD209b monoclonal antibodies from Santa Cruz Biotechnology support the scientific community in advancing immunology research and developing new therapeutic strategies.